Current Status of Bill S 3384
Bill S 3384 is currently in the status of Bill Introduced since March 3, 2020. Bill S 3384 was introduced during Congress 116 and was introduced to the Senate on March 3, 2020. Bill S 3384's most recent activity was Read twice and referred to the Committee on Finance. as of March 3, 2020
Bipartisan Support of Bill S 3384
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0
Policy Area and Potential Impact of Bill S 3384
Primary Policy Focus
HealthPotential Impact Areas
Administrative law and regulatory proceduresAdministrative remediesBusiness ethicsCanadaCivil actions and liabilityCompetition and antitrustDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationFederal Trade Commission (FTC)Food and Drug Administration (FDA)Government information and archivesHealth care costs and insuranceHealth information and medical recordsInflation and pricesIntellectual propertyLicensing and registrationsManufacturingMedicarePrescription drugsPublic participation and lobbyingTrade restrictions
Alternate Title(s) of Bill S 3384
Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020A bill to allow for negotiation of prices for certain covered Medicare part D drugs, to allow for importation by individuals of prescription drugs from Canada, to preserve access to affordable generics and biosimilars, to increase the use of real-time benefit tools to lower beneficiary costs, to establish a manufacturer discount program, and for other purposes.